Atlas Trials

Platinum-based Chemotherapy With Atezolizumab and Niraparib in Patients With Recurrent Ovarian Cancer

Clinical trial NCT03598270 · COMPLETED

Trial details

NCT number
NCT03598270
Sponsor
Grupo Español de Investigación en Cáncer de Ovario
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Recurrent Ovarian Carcinoma
Start date
2018-11-21
Primary completion
2024-08-05
Enrollment
417

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.